Fuzzle System for Obesity

JM
BE
Overseen ByBrandon Essink, MD
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores whether the Fuzzle intraoral device can aid adults with obesity in losing weight when combined with standard lifestyle counseling. Participants will either use the Fuzzle device, a removable mouthpiece worn during the day, or follow lifestyle counseling alone. The study aims to determine if the device leads to more significant weight loss compared to counseling alone over a 16-week period. It will also examine potential changes in certain metabolic markers, which indicate how the body processes food and energy, in some participants. This trial suits adults with a BMI of 30 or higher who are ready to engage in guided diet and behavior changes. As an unphased trial, it offers a unique opportunity to contribute to innovative research that could lead to new weight loss solutions.

Do I have to stop taking my current medications for the trial?

The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are currently using weight-loss medications.

What prior data suggests that the Fuzzle intraoral device is safe for use in adults with obesity?

Research has shown that the Fuzzle mouth device is likely safe and effective. In earlier studies, most users experienced no issues, with some losing weight in just two weeks and feeling motivated to continue. The device is designed to be low-risk, indicating general safety for users.

The FDA is currently reviewing Fuzzle for approval as a Class II medical device, which requires it to meet specific safety and performance standards. The device aims to help control appetite and manage weight and is currently used under general wellness guidelines.

Overall, early results suggest that while the device awaits full FDA approval, it is generally well-tolerated and considered low-risk. However, as with any new treatment, discussing potential risks and benefits with a healthcare provider before joining a trial is important.12345

Why are researchers excited about this trial?

Researchers are excited about the Fuzzle System for obesity because it introduces a novel approach through the use of an intraoral device. Unlike standard treatments, which often involve medications or surgical interventions, the Fuzzle System provides a non-invasive method that can be easily integrated into daily life. This device is worn during waking hours and works in conjunction with lifestyle management, potentially offering a more convenient and less intrusive option for managing obesity. Researchers hope this could lead to improved adherence and better outcomes for patients seeking weight loss solutions.

What evidence suggests that the Fuzzle intraoral device is effective for weight loss in obesity?

Research has shown that the Fuzzle mouth device might help people with obesity lose weight by reducing food intake and managing emotional eating. In this trial, participants in the investigational group will receive the Fuzzle intraoral device along with standardized lifestyle management. Early results suggest that similar devices often lead to greater weight loss, with some individuals losing at least 4% to 5% of their body weight. The device reduces "food noise," lessening the urge to eat when not truly hungry. Increased use of the device correlates with more significant weight loss. The Fuzzle system is being tested as a potential non-invasive option before more intensive treatments.12356

Who Is on the Research Team?

JM

Jeremy McConnell, MD

Principal Investigator

Dynamed Clinical Research

Are You a Good Fit for This Trial?

This trial is for adults aged 18-65 with obesity (BMI of 30 or higher) who are willing to follow lifestyle counseling and attend study visits. People can't join if they have certain dental issues, are pregnant or breastfeeding, have a history of eating disorders, unstable medical conditions, or recently used weight-loss medications.

Inclusion Criteria

Willing to comply with study visits and procedures
I am willing to take part in lifestyle counseling sessions.
Body mass index (BMI) ≥30 kg/m² at screening
See 2 more

Exclusion Criteria

Participation in another weight-loss clinical study within 90 days
Oral or dental conditions preventing safe device use
Pregnancy, breastfeeding, or intent to become pregnant during the study period
See 5 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive the Fuzzle intraoral device and/or standardized lifestyle counseling for weight management

16 weeks
Weekly check-ins (virtual or in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Fuzzle System

Trial Overview

The study compares two groups: one uses the Fuzzle oral device plus standard diet and behavior counseling; the other receives only lifestyle counseling. The goal is to see if adding the device helps more people lose weight over 16 weeks.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Active Control

Group I: Investigational group to receive Fuzzle intraoral deviceExperimental Treatment2 Interventions
Group II: Control group not to receive Fuzzle intraoral device.Active Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Fuzzle Operating Co.

Lead Sponsor

Dynamed Clinical Research

Collaborator

Advarra

Industry Sponsor

Trials
5
Recruited
680+

Citations

Fuzzle System for Obesity · Info for Participants

This study is evaluating whether the Fuzzle intraoral device can help adults with obesity lose weight when used alongside standard lifestyle ...

2.

fuzzle.com

fuzzle.com/partner

Innovative Behavioral Approach to Obesity Support

Provides real-time adherence and engagement data to help measure program performance and support outcome based models. Fuzzle is currently under FDA review as a ...

Breakthrough in Obesity Solutions: Fuzzle's Non-Invasive ...

The technology is evaluated as a potential step therapy before GLP-1 medications and as a valuable after-care option for individuals who have ...

Fuzzle System for Appetite Control and Weight Management

This study is evaluating whether the Fuzzle intraoral device can help adults with obesity lose weight when used alongside standard lifestyle counseling.

An intraoral device for weight loss: initial clinical findings - PMC

This study investigated the acceptability and tolerability of a novel intra-oral device to facilitate weight loss in obese patients. Tolerance ...

Efficacy and safety of an oral device to reduce food intake and ...

The System, a minimal risk tool, can help individuals achieve meaningful weight loss, when used with a lifestyle video.